 |
Interferon alfa-2b (recombinant) |
|---|---|
| Trade Name | Intron A |
| Orphan Indication | Carcinoma in situ of the urinary bladder |
| USA Market Approval | USA |
| USA Designation Date | 1988-08-10 00:00:00 |
| Sponsor | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 |
